| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.21 | 6e-10 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-08 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-08 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |